Krka, D.d., Novo Mesto opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Krka, D.d., Novo Mesto

Patent Number:
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
Opposition Date:
Dec 8, 2023
Patent Number:
Title:
Compositions Of Grapiprant And Methods For Using The Same
Opposition Date:
Sep 21, 2022
Patent Number:
Title:
Manufacturing Of Semi-Plastic Pharmaceutical Dosage Units
Opposition Date:
Jul 26, 2022
Patent Number:
Title:
Tablet Formulation Comprising A Peptide And A Delivery Agent
Opposition Date:
Jan 14, 2022
Patent Number:
Title:
Maropitant Formulation
Applicant:
Opposition Date:
Dec 23, 2021
Patent Number:
Title:
Methods And Compositions For Treating Cancer
Opposition Date:
Dec 22, 2021
Patent Number:
Title:
Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof
Opposition Date:
Dec 9, 2021
Patent Number:
Title:
Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia
Opposition Date:
Sep 30, 2021
Patent Number:
Title:
Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor
Applicant:
Opposition Date:
Apr 15, 2021
Patent Number:
Title:
Compositions Comprising Amlodipine And Bisoprolol
Opposition Date:
Oct 8, 2020

Latest patents of Krka, D.d., Novo Mesto opposed by its competitors

Patent:
Grant Date:
Nov 3, 2021
Title:
Processes For Crystallization Of Rivaroxaban
Oppositions:
1

Want to track Krka, D.d., Novo Mesto?

Feel free to send us a message here and we will get back to you